Your browser doesn't support javascript.
loading
Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.
Cautela, Jennifer; Zeriouh, Sarah; Gaubert, Melanie; Bonello, Laurent; Laine, Marc; Peyrol, Michael; Paganelli, Franck; Lalevee, Nathalie; Barlesi, Fabrice; Thuny, Franck.
Afiliação
  • Cautela J; University Mediterranean Centre of Cardio-Oncology (MEDI-CO centre), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Centre for CardioVascular and Nutrition research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, Assistance Publique - Hôpitaux
  • Zeriouh S; Mediterranean Group of Cardio-oncology (gMEDICO), Aix-Marseille-University, Marseille, Provence-Alpes-Côte d'Azur, France.
  • Gaubert M; University Mediterranean Centre of Cardio-Oncology (MEDI-CO centre), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Centre for CardioVascular and Nutrition research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, Assistance Publique - Hôpitaux
  • Bonello L; University Mediterranean Centre of Cardio-Oncology (MEDI-CO centre), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Centre for CardioVascular and Nutrition research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, Assistance Publique - Hôpitaux
  • Laine M; University Mediterranean Centre of Cardio-Oncology (MEDI-CO centre), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Centre for CardioVascular and Nutrition research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, Assistance Publique - Hôpitaux
  • Peyrol M; University Mediterranean Centre of Cardio-Oncology (MEDI-CO centre), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Centre for CardioVascular and Nutrition research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, Assistance Publique - Hôpitaux
  • Paganelli F; University Mediterranean Centre of Cardio-Oncology (MEDI-CO centre), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Centre for CardioVascular and Nutrition research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, Assistance Publique - Hôpitaux
  • Lalevee N; University Mediterranean Centre of Cardio-Oncology (MEDI-CO centre), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Centre for CardioVascular and Nutrition research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, Assistance Publique - Hôpitaux
  • Barlesi F; University Mediterranean Centre of Cardio-Oncology (MEDI-CO centre), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Centre for CardioVascular and Nutrition research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, Assistance Publique - Hôpitaux
  • Thuny F; Technological Advances for Genomics and Clinics (TAGC), UMR/INSERM 1090, Aix-Marseille-University, Marseille, France.
J Immunother Cancer ; 8(2)2020 12.
Article em En | MEDLINE | ID: mdl-33298621

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Imunossupressão / Inibidores de Checkpoint Imunológico / Miocardite Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Imunossupressão / Inibidores de Checkpoint Imunológico / Miocardite Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article